Catenion: Press Releases
Catenion to Attend Bio Europe Spring 2011
Catenion is proud to announce that it will attend Bio-Europe Spring 2011 in Milan, Italy. This partnering conference will be held on 14-16 March at the Milano Convention Centre (MIC). ...
Strategic M&A Support for Pharmaceutical and Biotech Companies - Minimising the Risk of 'Winner's Curse'
In a risky business driven by innovation, M&A is a vital strategic lever to counterbalance the in-built volatility of the R&D pipeline. In fact, there are many more reasons for frequent M&A...
Catenion Introduces Pre-Due Diligence and Due Diligence Support
Licensing and M&A activity has continued unabated in the bio-pharmaceutical space. The reasons are the impending patent cliff, which a number of the larger players have to face, as well as...
Upcoming Challenges for the Japanese Pharmaceutical Industry
The Japanese pharmaceutical industry accounts for more than 1,000 firms, of which approximately 20 have annual sales of more than $500m. It is a widespread view in the West that the...
Risk Profiles of Corporate Portfolio Strategies - A Perspective for the Pharmaceutical Executive
The current meltdown of some segments of the global banking system can be seen as a direct result of systemic weaknesses in the way that many financial services companies operated in a...
Introducing the Ideal Pharmaceutical Teaching Tool: Risky Business, The Pharmaceutical Industry Board Game
Risky Business, the pharmaceutical industry board game, is becoming a must-have when it comes to teaching about the pharmaceutical industry. Risky Business is a strategy training workshop...
